Short-term trial of etanercept in Behcet's disease: A double blind, placebo controlled study

Date
2005
Author
Yurdakul, Sebahattin
Melikoglu, Melike
Ozyazgan, Yılmaz
Hamuryudan, Vedat
Fresko, I
Mat, C
Gogus, F
Yazici, Hasan
Metadata
Show full item record
Abstract
Objective. To determine the effect of the tumor necrosis factor-a blocker-etanercept on the pathergy and monosodium urate (MSU) status and on the mucocutaneous and articular manifestations of patients with Behcet's disease (BD).
URI
http://hdl.handle.net/20.500.12627/137167
Collections